FDA Drug Application (203018) for HYDROCHLOROTHIAZIDE by SCIEGEN PHARMS INC

Back to FDA Applications sponsored by SCIEGEN PHARMS INC

Application Number203018
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameHYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by SCIEGEN PHARMS INC